Luojia Yang

Chinese PLA General Hospital

Papers

3

Total Citations

71

H-Index

3

About

Dr. Luojia Yang is a pioneering urologic surgeon whose work centers on robotic-assisted surgical management of complex renal and venous pathologies. Her most impactful contributions lie in developing decision-making frameworks for treating renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus. Her landmark multi-institutional study on robot-assisted cavectomy versus thrombectomy for Level II IVC thrombus (54 citations) established a critical, evidence-based algorithm for selecting the optimal surgical approach, directly improving patient outcomes in this high-risk procedure. Dr. Yang has also advanced the field of reconstructive urology, demonstrating through comparative analysis that robotic-assisted laparoscopic pyeloplasty is a safe and effective salvage option for recurrent ureteropelvic junction obstruction. Furthermore, her histological analysis of a large cohort of 350 RCC patients with tumor thrombus identified key survival-predictive features, providing essential prognostic information for clinicians. By combining rigorous clinical investigation with technical innovation, Dr. Yang has significantly shaped modern urologic oncology, offering safer, more effective surgical solutions for some of the most challenging conditions in the specialty.

Research Focus

Key Achievements

3
H-Index
3
Papers
71
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional Analysis
54 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago